These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

443 related articles for article (PubMed ID: 33404102)

  • 1. Vitiligo: A focus on pathogenesis and its therapeutic implications.
    Bergqvist C; Ezzedine K
    J Dermatol; 2021 Mar; 48(3):252-270. PubMed ID: 33404102
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vitiligo: Mechanisms of Pathogenesis and Treatment.
    Frisoli ML; Essien K; Harris JE
    Annu Rev Immunol; 2020 Apr; 38():621-648. PubMed ID: 32017656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vitiligo: A Review.
    Bergqvist C; Ezzedine K
    Dermatology; 2020; 236(6):571-592. PubMed ID: 32155629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The IFN-γ-CXCL9/CXCL10-CXCR3 axis in vitiligo: Pathological mechanism and treatment.
    Liu H; Wang Y; Le Q; Tong J; Wang H
    Eur J Immunol; 2024 Apr; 54(4):e2250281. PubMed ID: 37937817
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Type-1 cytokines regulate MMP-9 production and E-cadherin disruption to promote melanocyte loss in vitiligo.
    Boukhedouni N; Martins C; Darrigade AS; Drullion C; Rambert J; Barrault C; Garnier J; Jacquemin C; Thiolat D; Lucchese F; Morel F; Ezzedine K; Taieb A; Bernard FX; Seneschal J; Boniface K
    JCI Insight; 2020 Jun; 5(11):. PubMed ID: 32369451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current Concepts of Vitiligo Immunopathogenesis.
    Hlača N; Žagar T; Kaštelan M; Brajac I; Prpić-Massari L
    Biomedicines; 2022 Jul; 10(7):. PubMed ID: 35884944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emerging role of Tissue Resident Memory T cells in vitiligo: From pathogenesis to therapeutics.
    Shah F; Patel S; Begum R; Dwivedi M
    Autoimmun Rev; 2021 Aug; 20(8):102868. PubMed ID: 34118458
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Keratinocyte-Derived Chemokines Orchestrate T-Cell Positioning in the Epidermis during Vitiligo and May Serve as Biomarkers of Disease.
    Richmond JM; Bangari DS; Essien KI; Currimbhoy SD; Groom JR; Pandya AG; Youd ME; Luster AD; Harris JE
    J Invest Dermatol; 2017 Feb; 137(2):350-358. PubMed ID: 27686391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ISG15-USP18 Dysregulation by Oxidative Stress Promotes IFN-γ Secretion from CD8+ T Cells in Vitiligo.
    Lee EJ; Kim JY; Yeo JH; Park S; Bae YJ; Kwon IJ; Seong SH; Lee J; Oh SH
    J Invest Dermatol; 2024 Feb; 144(2):273-283.e11. PubMed ID: 37625543
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vitiligo: An Autoimmune Skin Disease and its Immunomodulatory Therapeutic Intervention.
    Chang WL; Lee WR; Kuo YC; Huang YH
    Front Cell Dev Biol; 2021; 9():797026. PubMed ID: 34970551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunometabolism in the pathogenesis of vitiligo.
    Lyu C; Sun Y
    Front Immunol; 2022; 13():1055958. PubMed ID: 36439174
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Janus Kinase Inhibitors in the Treatment of Vitiligo: A Review.
    Qi F; Liu F; Gao L
    Front Immunol; 2021; 12():790125. PubMed ID: 34868078
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A mouse model of vitiligo with focused epidermal depigmentation requires IFN-γ for autoreactive CD8⁺ T-cell accumulation in the skin.
    Harris JE; Harris TH; Weninger W; Wherry EJ; Hunter CA; Turka LA
    J Invest Dermatol; 2012 Jul; 132(7):1869-76. PubMed ID: 22297636
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Role of T
    Frączek A; Owczarczyk-Saczonek A; Placek W
    Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32443482
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interferon-gamma Inhibits Melanogenesis and Induces Apoptosis in Melanocytes: A Pivotal Role of CD8+ Cytotoxic T Lymphocytes in Vitiligo.
    Yang L; Wei Y; Sun Y; Shi W; Yang J; Zhu L; Li M
    Acta Derm Venereol; 2015 Jul; 95(6):664-70. PubMed ID: 25721262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perspectives of New Advances in the Pathogenesis of Vitiligo: From Oxidative Stress to Autoimmunity.
    Wang Y; Li S; Li C
    Med Sci Monit; 2019 Feb; 25():1017-1023. PubMed ID: 30723188
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vitiligo: Mechanistic insights lead to novel treatments.
    Frisoli ML; Harris JE
    J Allergy Clin Immunol; 2017 Sep; 140(3):654-662. PubMed ID: 28778794
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Understanding mechanisms of autoimmunity through translational research in vitiligo.
    Strassner JP; Harris JE
    Curr Opin Immunol; 2016 Dec; 43():81-88. PubMed ID: 27764715
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical Features, Immunopathogenesis, and Therapeutic Strategies in Vitiligo.
    Wang Y; Li S; Li C
    Clin Rev Allergy Immunol; 2021 Dec; 61(3):299-323. PubMed ID: 34283349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vitiligo: Focus on Clinical Aspects, Immunopathogenesis, and Therapy.
    Boniface K; Seneschal J; Picardo M; Taïeb A
    Clin Rev Allergy Immunol; 2018 Feb; 54(1):52-67. PubMed ID: 28685247
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.